MENU
MRSN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Mersana Therapeutics (MRSN) Ownership - Who owns Mersana Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
840 Memorial Drive
Phone
+1 617 498-0020
Employees
123
Web
https://www.mersana.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
196.42M
P/E Ratio
N/A
Total Cash
155.17M
Projected Growth
N/A
Total Debt
31.51M
Revenue
34.84M
Risk (Beta)
0.26
Dividend Yield
N/A
Total Cash/Share
1.26
Total Debt/Equity
N/A
Revenue/Share
0.29 USD as % of share price
Fundamentals
MRSN
Capitalization
196M
P/E Ratio
N/A
Risk (Beta)
0.26
Dividend Yield
N/A
Total Cash
155M
Total Cash/Share
1.26
Total Debt
31.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.29%
Revenue
34.8M
ROE
N/A
Book Value
1.05M
P/B Ratio
188.68
Cash Flow
N/A
Earnings
-0.6
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
12K
Current Ratio
2.35
Current Revenue Per Employee
102422.77
Dividends Per Share - Security
N/A
EBITDA
-68.51M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-34.51
Shares Held By Institutions
276M
Shares Outstanding - Current
124M
Total Liabilities
168M
Total Volume MTD
N/A
Value
-1
Gain YTD
-31.034
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of antibody drug conjugates to improve patient outcomes in multiple oncology indications
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
840 Memorial Drive
Phone
+1 617 498-0020
Employees
123
Web
https://www.mersana.com